Buprenorphine-Precipitated Withdrawal Hotspots and Correlates

Identifying Regional “Hotspots” and Potential Correlates of Precipitated Withdrawal During Buprenorphine Induction in Fentanyl Users Through Prescriber Survey Responses and Patient Urine Drug Test Results

This study has two primary aims:

  • Aim 1 is to characterize the regional variability in the prevalence of prescriber-reported precipitated withdrawal during buprenorphine induction for individuals using fentanyl in > 250 counties in the U.S.
  • Aim 2 is to identify potential correlates of buprenorphine-precipitated withdrawal in fentanyl users.
CTN Protocol ID: 
CTN-0134
Status: 
Development

Principal Investigator(s)

LaTrice Montgomery, Ph.D.

Research Associate Professor
University of Cincinnati
Center for Addiction Research, Addiction Sciences Division
Department of Psychiatry, College of Medicine

3131 Harvey Avenue, Suite 204
Cincinnati, OH 45229
United States

T. John Winhusen, Ph.D.

Professor of Psychiatry and Behavioral Neuroscience, Director of Addiction Sciences Division
University of Cincinnati
Addiction Sciences Division

3131 Harvey Avenue, Suite 104
Cincinnati, OH 45229-3006
United States